Article
Cardiac & Cardiovascular Systems
Finn Akerstrom, Julie Hutter, Emmanouil Charitakis, Fariborz Tabrizi, Fahd Asaad, Hamid Bastani, Tara Bourke, Frieder Braunschweig, Nikola Drca, Anders Englund, Leif Friberg, Per Insulander, Anders Hassel Jonsson, Goran Kenneback, Astrid Paul-Nordin, Bita Sadigh, Ott Saluveer, Serkan Saygi, Jonas Schwieler, Emma Svennberg, Jari Tapanainen, Yusuf Turkmen, Mats Jensen-Urstad
Summary: Catheter ablation of atrial fibrillation is associated with a lower risk of all-cause mortality or stroke.
Review
Cardiac & Cardiovascular Systems
Derek Chew, Jonathan P. Piccini
Summary: Catheter ablation is more effective than antiarrhythmic therapy in reducing symptomatic AF, recurrence, and burden. The debate on rate vs. rhythm control has been reopened, potentially impacting stroke risk. Discontinuation of oral anticoagulation post-ablation may increase stroke risk, highlighting the need for further randomized controlled trials to determine the appropriate management.
Article
Hematology
Zhimin Dong, Xiaoxia Hou, Xin Du, Liu He, Jianzeng Dong, Changsheng Ma
Summary: A study from China-AF Registry found that DOACs and warfarin had similar effectiveness and safety in preventing thromboembolic events and major bleeding in patients undergoing catheter ablation for atrial fibrillation. However, rivaroxaban had a higher risk of non-major bleeding compared to warfarin and low-dose dabigatran.
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS
(2022)
Article
Cardiac & Cardiovascular Systems
Stijn P. G. van Vugt, Sjoerd W. Westra, Rick H. J. A. Volleberg, Gerjon Hannink, Rena Nakamura, Carlo de Asmundis, Gian-Battista Chierchia, Eliano P. Navarese, Marc A. Brouwer
Summary: This study summarizes the use of mi-NOAC in catheter ablation for atrial fibrillation, showing that overall clinical outcomes were similar to continuous NOAC use, and there was no lower bleeding rates despite preprocedural interruption. Further high-volume datasets are needed for more precise estimations of treatment effects in AF ablation.
Article
Multidisciplinary Sciences
Wei-Ru Chiou, Po-Lin Lin, Chun-Che Huang, Jen-Yu Chuang, Lawrence Yu-Min Liu, Min- Su, Feng-Ching Liao, Jen-Yuan Kuo, Cheng-Ting Tsai, Yih-Jer Wu, Kuang-Te Wang, Ying-Hsiang Lee
Summary: This study compares the outcomes of rivaroxaban with and without concomitant antiarrhythmic drugs for patients with non-permanent AF. The results suggest that the concomitant use of rivaroxaban with AADs can reduce the risk of thromboembolism and all-cause death, but may increase the occurrence of congestive heart failure.
SCIENTIFIC REPORTS
(2022)
Review
Cardiac & Cardiovascular Systems
Riccardo Cappato, Hussam Ali
Summary: Surveys and registries have been valuable tools in investigating various aspects of catheter ablation of atrial fibrillation, such as safety, efficacy, discontinuation of anticoagulation therapy, and outcomes in special populations, over the past 15 years.
CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY
(2021)
Article
Cardiac & Cardiovascular Systems
Jien-Jiun Chen, Fu-Chun Chiu, Sheng-Nan Chang, Hsiao-Liang Cheng, Pang-shuo Huang, Cho-Kai Wu, Yi-Chih Wang, Juey-Jen Hwang, Chia-Ti Tsai
Summary: This pioneer study investigated the impact of pre-existing left atrial appendage occluder (LAAO) on atrial fibrillation (AF) substrates and outcomes of pulmonary vein isolation (PVI). Results showed that LAAO may modulate left atrial substrate and induce peridevice fibrosis, peridevice left atrial flutter, and complex fractionate atrial electrogram.
Editorial Material
Cardiac & Cardiovascular Systems
David Zweiker, Martin Manninger, Raphael Sieghartsleitner, Jakob Ebner, Bernadette Pratl, Egbert Bisping, Peter Lercher, Dirk von Lewinski, Rita Riedlbauer, Ursula Rohrer, Henri M. H. Spronk, Andreas Zirlik, Ulrich Schotten, Daniel Scherr
Summary: This study analyzed the impact of DOAC treatment on recurrence-free survival after AF catheter ablation, showing that despite better baseline characteristics for DOAC patients, arrhythmia-free survival was similar in both groups.
INTERNATIONAL JOURNAL OF CARDIOLOGY
(2021)
Article
Cardiac & Cardiovascular Systems
Min Kim, Hee Tae Yu, JongYoun Kim, Tae-Hoon Kim, Jae-Sun Uhm, Boyoung Joung, Moon-Hyoung Lee, Hui-Nam Pak
Summary: Atrial fibrillation catheter ablation significantly reduces the risk of ischemic stroke and intracranial hemorrhage in patients with AF, compared to medical therapy, to the extent of the non-AF population. Post-procedural AF control influences the risk of ischemic strokes.
Article
Medicine, General & Internal
Urs Fischer, Masatoshi Koga, Daniel Strbian, Mattia Branca, Stefanie Abend, Sven Trelle, Maurizio Paciaroni, Goetz Thomalla, Patrik Michel, Krassen Nedeltchev, Leo H. Bonati, George Ntaios, Thomas Gattringer, Else-Charlotte Sandset, Peter Kelly, Robin Lemmens, P. N. Sylaja, Diana Aguiar de Sousa, Natan M. Bornstein, Zuzana Gdovinova, Takeshi Yoshimoto, Marjaana Tiainen, Helen Thomas, Manju Krishnan, Gek C. Shim, Christoph Gumbinger, Jochen Vehoff, Liqun Zhang, Kosuke Matsuzono, Espen Kristoffersen, Philippe Desfontaines, Peter Vanacker, Angelika Alonso, Yusuke Yakushiji, Caterina Kulyk, Dimitri Hemelsoet, Sven Poli, Ana Paiva Nunes, Nicoletta Caracciolo, Peter Slade, Jelle Demeestere, Alexander Salerno, Markus Kneihsl, Timo Kahles, Daria Giudici, Kanta Tanaka, Silja Raty, Rea Hidalgo, David J. Werring, Martina Goldlin, Marcel Arnold, Cecilia Ferrari, Seraina Beyeler, Christian Fung, Bruno J. Weder, Turgut Tatlisumak, Sabine Fenzl, Beata Rezny-Kasprzak, Arsany Hakim, Georgia Salanti, Claudio Bassetti, Jan Gralla, David J. Seiffge, Thomas Horvath, Jesse Dawson
Summary: This study aimed to compare the effect of early initiation versus later initiation of direct oral anticoagulants (DOACs) on acute ischemic stroke in patients with atrial fibrillation. The results showed that there was no significant difference in the incidence of recurrent ischemic stroke, systemic embolism, major extracranial bleeding, symptomatic intracranial hemorrhage, or vascular death within 30 days between early and later use of DOACs.
NEW ENGLAND JOURNAL OF MEDICINE
(2023)
Article
Cardiac & Cardiovascular Systems
Andrew S. Tseng, Harsh P. Patel, Ashish Kumar, Chinmay Jani, Kirtenkumar Patel, Rahul Jaswaney, Samarthkumar Thakkar, Narayan G. Kowlgi, Sourbha S. Dani, Shilpkumar Arora, Siva K. Mulpuru, Malini Madhavan, Ammar M. Killu, Yong-Mei Cha, Christopher V. DeSimone, Abhishek Deshmukh
Summary: Based on an analysis of nationwide hospitalized patient data, catheter ablation was found to be associated with a reduction in one-year readmission for atrial fibrillation and all-cause readmissions among younger patients aged 18 to 50.
BMC CARDIOVASCULAR DISORDERS
(2023)
Article
Cardiac & Cardiovascular Systems
Darae Ko, Connor Saleeba, Hammad Sadiq, Sybil Crawford, Tenes Paul, Qiming Shi, Ziyue Wang, Emelia J. Benjamin, Allan J. Walkey, Steven A. Lubitz, Alok Kapoor, David McManus
Summary: The study revealed a lower usage of oral anticoagulants in patients with secondary AF precipitated by acute conditions in contemporary clinical practice.
JOURNAL OF THE AMERICAN HEART ASSOCIATION
(2021)
Article
Clinical Neurology
Lamiae Grimaldi-Bensouda, Jean-Yves Le Heuzey, Jean Ferrieres, Didier Leys, Jean-Marc Davy, Mikel Martinez, Olivia Dialla, Didier Smadja, Norbert Nighoghossian, Jacques Benichou, Clementine Nordon, Emmanuel Touze, Lucien Abenhaim
Summary: Individual direct oral anticoagulants show better efficacy compared to vitamin K antagonists in primary stroke prevention in patients with atrial fibrillation, regardless of the presence of permanent AF.
Article
Clinical Neurology
Peter Bronnum Nielsen, Line Melgaard, Thure Filskov Overvad, Martin Jensen, Torben Bjerregaard Larsen, Gregory Y. H. Lip
Summary: The study found that patients with ICH and AF have a high risk of cerebrovascular ischemic events and a very high risk of all-cause death one year after the incident. Further clinical trials are needed to determine the optimal stroke prevention treatment for ICH survivors with AF.
Review
Cardiac & Cardiovascular Systems
Gianluigi Bisleri, Arjun K. Pandey, Subodh Verma, Syed M. Ali Hassan, Bobby Yanagawa, Masud Khandaker, Mario Gaudino, Andrea M. Russo, Atul Verma, Deepak L. Bhatt, Andrew C. T. Ha
Summary: Hybrid ablation is a novel therapy that combines minimally invasive surgical and percutaneous catheter-based techniques for the management of atrial fibrillation (AF). Observational studies have shown approximately 70% success rates but higher risks compared to catheter-based ablation. Hybrid ablation is typically offered to patients with persistent or longstanding persistent AF, requiring two procedures. While a randomized trial demonstrated its superiority over catheter-based ablation, it also showed higher complication rates. Contemporary studies have shown a decrease in the incidence of serious complications. Additional randomized trials are needed to determine the risks, benefits, and cost effectiveness of hybrid ablation in clinical practice.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
(2023)
Article
Cardiac & Cardiovascular Systems
John Rickard, Mohamed Bassiouny, Edmond M. Cronin, David O. Martin, Niraj Varma, Mark J. Niebauer, Patrick J. Tchou, W. H. Wilson Tang, Bruce L. Wilkoff
AMERICAN JOURNAL OF CARDIOLOGY
(2011)
Letter
Cardiac & Cardiovascular Systems
Mohamed Bassiouny, Walid Saliba, John Rickard, Mingyuan Shao, Albert Sey, Mariam Diab, David O. Martin, Ayman Hussein, Maurice Khoury, Bernard Abi-Saleh, Samir Alam, Jay Sengupta, P. Peter Borek, Bryan Baranowski, Mark Niebauer, Thomas Callahan, Niraj Varma, Mina Chung, Patrick J. Tchou, Mohamed Kanj, Thomas Dresing, Bruce D. Lindsay, Oussama Wazni
CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY
(2013)
Article
Cardiac & Cardiovascular Systems
Jay Sengupta, Arthur C. Kendig, Marlene Goormastic, Eui-Seock Hwang, Elizabeth A. Ching, Roy Chung, Bruce D. Lindsay, Patrick J. Tchou, Bruce L. Wilkoff, Mark J. Niebauer, David O. Martin, Niraj Varma, Oussama Wazni, Walid Saliba, Mohamed Kanj, Mandeep Bhargava, Thomas Dresing, Tyler Taigen, Christopher Ingelmo, Mohamed Bassiouny, Edmond M. Cronin, Bradley Wilsmore, John Rickard, Mina K. Chung
Article
Cardiac & Cardiovascular Systems
Bryan Baranowski, Oussama Wazni, Roy Chung, David O. Martin, John Rickard, Christine Tanaka-Esposito, Mohammed Bassiouny, Bruce L. Wilkoff